Skip to content

HUBEI MINKANG PHARMACEUTICAL LTD.: 10-Q/A filed 2012-01-17

What HUBEI MINKANG PHARMACEUTICAL LTD. reported in its quarterly report amendment filed 2012-01-17 (fiscal Q3 2011): 33 published measures, 91 facts as tagged in accession 0001144204-12-002561.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-Q/A (quarterly report amendment)
Filed
2012-01-17
Fiscal period
fiscal Q3 2011
Accession
0001144204-12-002561 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All HUBEI MINKANG PHARMACEUTICAL LTD. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-09-3016,883,512USD
At 2010-12-3114,533,099USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-09-309,107,290USD
At 2010-12-316,955,167USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-09-307,776,222USD
At 2010-12-317,577,932USD
At 2009-12-315,142,510USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-341,702USD92
2011-01-01 to 2011-09-3065,813USD273
2010-01-01 to 2010-12-312,204,431USD365
2010-07-01 to 2010-09-301,062,733USD92
2010-01-01 to 2010-09-302,111,129USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-872,194USD273
2010-01-01 to 2010-09-303,061,156USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-01-01 to 2011-09-3038,418USD273
2010-01-01 to 2010-09-30496,426USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2011-07-01 to 2011-09-303,181,496USD92
2011-01-01 to 2011-09-308,305,281USD273
2010-07-01 to 2010-09-304,461,102USD92
2010-01-01 to 2010-09-3011,067,250USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-09-302,598,477USD273
2010-01-01 to 2010-09-30-313,522USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-35,514USD273
2010-01-01 to 2010-09-30-496,426USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-09-303,024,458USD
At 2010-12-312,958,645USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-68,204USD92
2011-01-01 to 2011-09-3053,466USD273
2010-07-01 to 2010-09-30427,933USD92
2010-01-01 to 2010-09-30804,118USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-09-304,500,557USD
At 2010-12-314,545,131USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-329,125USD92
2011-01-01 to 2011-09-30244,256USD273
2010-07-01 to 2010-09-301,450,806USD92
2010-01-01 to 2010-09-303,034,436USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-09-309,675,228USD
At 2010-12-317,197,228USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2011-07-01 to 2011-09-3050,135USD92
2011-01-01 to 2011-09-30118,873USD273
2010-07-01 to 2010-09-3039,198USD92
2010-01-01 to 2010-09-30119,909USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-09-309,107,290USD
At 2010-12-316,955,167USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-09-302,429,302USD
At 2010-12-312,515,884USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2011-09-301,809,405USD
At 2010-12-312,325,674USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2011-09-302,956,992USD
At 2010-12-312,408,027USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2011-07-01 to 2011-09-301,571,348USD92
2011-01-01 to 2011-09-304,051,610USD273
2010-07-01 to 2010-09-302,468,117USD92
2010-01-01 to 2010-09-306,049,348USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-07-01 to 2011-09-3020,386USD92
2011-01-01 to 2011-09-3031,416USD273
2010-07-01 to 2010-09-3021,293USD92
2010-01-01 to 2010-09-3036,180USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-09-3043,047,169shares
At 2010-12-3133,500,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-09-303,439,480USD
At 2010-12-313,586,500USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2011-09-305,378,473USD
At 2010-12-315,165,118USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2011-09-30877,916USD
At 2010-12-31619,987USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2011-09-30164,736USD
At 2010-12-3140,878USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-248,071USD92
2011-01-01 to 2011-09-30335,763USD273
2010-01-01 to 2010-12-312,435,422USD365
2010-07-01 to 2010-09-301,181,191USD92
2010-01-01 to 2010-09-302,252,789USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-07-01 to 2011-09-30484,678USD92
2011-01-01 to 2011-09-301,552,153USD273
2010-07-01 to 2010-09-30423,283USD92
2010-01-01 to 2010-09-301,335,903USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-19,086USD92
2011-01-01 to 2011-09-30-14,422USD273
2010-07-01 to 2010-09-3070,016USD92
2010-01-01 to 2010-09-30-11,004USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-80,781USD92
2011-01-01 to 2011-09-30-124,977USD273
2010-07-01 to 2010-09-3039,860USD92
2010-01-01 to 2010-09-30-119,189USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-595,038USD273
2010-01-01 to 2010-09-30414,873USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-09-30467,409USD273
2010-01-01 to 2010-09-3047,045USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-309,823USD273
2010-01-01 to 2010-09-30289,301USD273

Inspect the source

Entity
HUBEI MINKANG PHARMACEUTICAL LTD. / CIK 0001375850
Captured
SEC response SHA-256
b8348a79d6f66b92634596f38c33d5732b102db30758c0391226a367b9c4a8aa

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001375850.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))